Larios-Cervantes Alexis Alberto

Larios-Cervantes Alexis Alberto

Auto-generated profile, based on publicly available information

Larios-Cervantes Alexis Alberto

Department of Chemical Engineering, Faculty of Engineering McMaster University Hamilton Ontario Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2021 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
LALarios-Cervantes Alexis Alberto
Larios-Cervantes Alexis Alberto
CGChávez-Cortéz Elda Georgina
Chávez-Cortéz Elda Georgina
Miryam Martínez-HernándezMiryam Martínez-Hernández
Miryam Martínez-Hernández
LCLuis Gabriel Talavera Contreras
Luis Gabriel Talavera Contreras
AEAdrián Espinoza-Guillén
Adrián Espinoza-Guillén
VMVictor Martinez-Aguilar
Victor Martinez-Aguilar
Objectives The present study aims to evaluate the antimicrobial property of Casiopeinas® copper- and ruthenium-based compounds against Aggregatibacter actinomycetemcomitans serotype b (ATCC® 43,718™), as well as the cytotoxicity on an osteoblasts cell line of both compounds. Material and methods The antibacterial effect of the copper-based compounds (CasII-gly, CasIII-ia) and the ruthenium-based compound (RuN-6) at four different concentrations was evaluated as the inhibition ratio of the bacterial growth after 48 h under anaerobic conditions, and the cell viability was measured through resazurin assay. Results The copper- and ruthenium-based compounds used for this assay were (CasII-gly, CasIII-ia, and RuN-6), showing inhibitory activity between 39 and 62% compared to the antibiotic employed as control 66%. Cell viability was established between 61 and 96%. Conclusions Casiopeinas® and ruthenium showed dose and time dependent, inhibitory activity on A. actinomycetemcomitans, and low toxicity on cells (osteoblast) underexposure. The compound CasII-gly showed the best antimicrobial effect, and it could be considered a possible antimicrobial agent in periodontal therapy.

30 April 2025 in Odovtos - International Journal of Dental Sciences
Verified
Journal Article
Open access
PDF file
CMClaudina Marcín-Montero
Claudina Marcín-Montero
VMVictor Martinez-Aguilar
Victor Martinez-Aguilar
RCRubén Castillo-Bolio
Rubén Castillo-Bolio
EPEsteban Mena Porras
Esteban Mena Porras
Amaury Pozos-GuillénAmaury Pozos-Guillén
Amaury Pozos-Guillén
Daniel Chavarria-BolanosDaniel Chavarria-Bolanos
Daniel Chavarria-Bolanos
Pre-prosthetic surgical procedures such as clinical crown lengthening (CLS), can cause pain, discomfort, and postoperative inflammation; causing the need of the prescription of medications such as analgesic, anti-inflammatories and in certain cases systemic antibiotics. However, prolonged and indiscriminate use of these medications often leads to adverse effects on general health. Thus, the ideal to treat locally pain and inflammation, and to prevent local infection is promising. The objective of this preliminary study was to evaluate the controlled use of a local chlorhexidine gel (CHXg) immediately place after pre-prosthetic periodontal surgery to manage postoperative pain using a customized whitening trays. A randomized controlled double-blind parallel-group clinical pilot trial was conducted. A sample of 10 patients aged 18 to 60 years, requiring a crown lengthening procedure was selected. Two groups (Group A: 0.2% CHXg vs Group B: placebo gel). Pain scores were evaluated by using a visual analog scale (VAS), and side effects and poswas 3.32 for Group A and 4.85 for Group B (p=0.05), with results showing no statistically significant difference. Few studies have assessed the effect and influence of 0.2% CHX gel on postoperative pain control. Some reports suggest that intra-alveolar use of CHX gel is more effective than administering 10 mg of ketorolac alone. In this study, there were no statistically significant differences, indicating that the use of 0.2% CHX gel applied after pre-prosthetic surgery may not significantly reduce postoperative pain.

9 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
AAAfshin Abrishamkar
Afshin Abrishamkar
LNLaura Neely
Laura Neely
CPCynthia Pham
Cynthia Pham
NINada Ibrahim
Nada Ibrahim
ALAlexis Larios‐Cervantes
Alexis Larios‐Cervantes
THTodd Hoare
Todd Hoare
Microparticles of hydrogels, also known as microgels, have garnered extensive attention due to their versatile properties and wide range of applications in different fields of science, technology, and medicine. Among the developed technologies to produce microgels, the precise control over fluid handling offered by microfluidics enables particular fine‐tuning of the shape, size, and composition of microgels. This article provides a review of recent progress in the development of microfluidic technologies for the fabrication of microgels based on different hydrogel‐based biomaterials for diverse practical applications. The fundamental principles of different microfluidic‐based techniques for microgel formation are summarized including chip‐based, capillary‐based, valve‐based, three‐dimensional printed, and digital microfluidics. Following, strategies for producing microgels from various natural and synthetic polymers using a range of potential crosslinking techniques with varying sizes, structures (water‐in‐oil, oil‐in‐water, higher order emulsion, and core‐shell), and morphologies (spherical, non‐spherical, Janus, and porous) are discussed in detail. Subsequently, the practical applications of microgels produced via microfluidic technologies are summarized across various fields including cell encapsulation, tissue engineering, particle removal, sensors, and food and nutrition, with current challenges and opportunities highlighted to motivate future research in the field.